Value Star Asset Management (Hong Kong) LTD Novo Cure LTD Call Options Transaction History

Value Star Asset Management (Hong Kong) LTD

$26.7 Billion
Q3 2024

Call Options

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 09, 2022	SELL	$75.08 - $121.99 $75,080 - $121,990	-1,000 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$116.17 - $194.55 $116,170 - $194,550	-1,000 Reduced 50.0%	1,000 $116,000
Q2 2021 Aug 03, 2021	BUY	$130.4 - $225.58 $260,800 - $451,160	2,000 New	2,000 $443,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$360 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$351 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$235 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$128 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$89.9 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.11B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Value Star Asset Management (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Value Star Asset Management (Hong Kong) LTD with notifications on news.

Account